Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3Β-dependent and Β-catenin-independent mechanism

Differentiation

Volumn 80, Issue 1, 2010, Pages 46-52

  Fukuda, Toru ^a   Kokabu, Shoichiro ^a   Ohte, Satoshi ^a   Sasanuma, Hiroki ^a   Kanomata, Kazuhiro ^a   Yoneyama, Katsumi ^a   Kato, Hitoshi ^b   Akita, Masumi ^a   Oda, Hiromi ^a   Katagiri, Takenobu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

BMP; GSK3 ; Osteoblastic differentiation; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; NOGGIN; OSTEONECTIN; SMAD PROTEIN; WNT PROTEIN; WNT1 PROTEIN; WNT11 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LUCIFERASE; MESSENGER RNA; SMAD1 PROTEIN; SMAD1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; MYOBLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; GLYCOGEN SYNTHASE KINASE 3; LUCIFERASES; MICE; MYOBLASTS; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; WNT PROTEINS;

EID: 77954145629     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.05.002     Document Type: Article

References (46)

1. Aubin J.E. Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2001, 2:81-94.
2. Bain G., Muller T., Wang X., Papkoff J. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 2003, 301:84-91.
3. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., MacDougald O.A. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U S A 2005, 102:3324-3329.
4. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., Wu D., Insogna K., Lifton R.P. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 2002, 346:1513-1521.
5. Chen Y., Whetstone H.C., Youn A., Nadesan P., Chow E.C., Lin A.C., Alman B.A. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 2007, 282:526-533.
6. Friedman M.S., Oyserman S.M., Hankenson K.D. Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2. J. Biol. Chem. 2009, 284:14117-14125.
7. Fukuda T., Kanomata K., Nojima J., Kokabu S., Akita M., Ikebuchi K., Jimi E., Komori T., Maruki Y., Matsuoka M., Miyazono K., Nakayama K., Nanba A., Tomoda H., Okazaki Y., Ohtake A., Oda H., Owan I., Yoda T., Haga N., Furuya H., Katagiri T. A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem. Biophys. Res. Commun. 2008, 377:905-909.
8. Fukuda T., Kohda M., Kanomata K., Nojima J., Nakamura A., Kamizono J., Noguchi Y., Iwakiri K., Kondo T., Kurose J., Endo K., Awakura T., Fukushi J., Nakashima Y., Chiyonobu T., Kawara A., Nishida Y., Wada I., Akita M., Komori T., Nakayama K., Nanba A., Maruki Y., Yoda T., Tomoda H., Yu P.B., Shore E.M., Kaplan F.S., Miyazono K., Matsuoka M., Ikebuchi K., Ohtake A., Oda H., Jimi E., Owan I., Okazaki Y., Katagiri T. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J. Biol. Chem. 2009, 284:7149-7156.
9. Goldman L.A., Cutrone E.C., Kotenko S.V., Krause C.D., Langer J.A. Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques 1996, 21:1013-1015.
10. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W.N., Allgrove J., Arslan-Kirchner M., Batch J.A., Beighton P., Black G.C., Boles R.G., Boon L.M., Borrone C., Brunner H.G., Carle G.F., Dallapiccola B., De Paepe A., Floege B., Halfhide M.L., Hall B., Hennekam R.C., Hirose T., Jans A., Juppner H., Kim C.A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R.S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., van den Boogaard M.J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B.R., Warman M.L. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
11. Huelsken J., Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 2001, 11:547-553.
12. Iwasaki S., Iguchi M., Watanabe K., Hoshino R., Tsujimoto M., Kohno M. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J. Biol. Chem. 1999, 274:26503-26510.
13. Kamiya, N., Kobayashi, T., Mochida, Y., Yu, P.B., Yamauchi, M., Kronenberg, H.M., and Mishina, Y. (2009) Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the Type IA receptor (BMPRIA) in osteoblasts. J. Bone Miner. Res.
14. Kamiya N., Ye L., Kobayashi T., Lucas D.J., Mochida Y., Yamauchi M., Kronenberg H.M., Feng J.Q., Mishina Y. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J. Bone Miner. Res. 2008, 23:2007-2017.
15. Kamiya N., Ye L., Kobayashi T., Mochida Y., Yamauchi M., Kronenberg H.M., Feng J.Q., Mishina Y. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008, 135:3801-3811.
16. Kanomata K., Kokabu S., Nojima J., Fukuda T., Katagiri T. DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts. Genes Cells 2009, 14:695-702.
17. Katagiri T. Heterotopic bone formation induced by bone morphogenetic protein signaling: fibrodysplasia ossificans progressiva. J. Oral Biosci. 2010, 52:33-41.
18. Katagiri T., Imada M., Yanai T., Suda T., Takahashi N., Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 2002, 7:949-960.
19. Katagiri T., Suda T., Miyazono K. The bone morphogenetic proteins. The TGF-Β Family 2008, 121-149. Cold Spring Harbor Press, New York. K. Miyazono, R. Derynck (Eds.).
20. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
21. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass D.A., Hartmann C., Li L., Hwang T.H., Brayton C.F., Lang R.A., Karsenty G., Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 2002, 157:303-314.
22. Kodaira K., Imada M., Goto M., Tomoyasu A., Fukuda T., Kamijo R., Suda T., Higashio K., Katagiri T. Purification and identification of a BMP-like factor from bovine serum. Biochem. Biophys. Res. Commun. 2006, 345:1224-1231.
23. Kokabu, S., Nojima, J., Kanomata, K., Ohte, S., Yoda, T., Fukuda, T., and Katagiri, T. 2010. Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J. Bone Miner. Res. 25, 653-660.
24. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 gene. J. Biol. Chem. 2002, 277:4883-4891.
25. Kugimiya F., Kawaguchi H., Ohba S., Kawamura N., Hirata M., Chinked H., Azuma Y., Woodgett J.R., Nakamura K., Chung U.I. GSK-3beta controls osteogenesis through regulating Runx2 activity. PLoS One 2007, 2:e837.
26. Lane K.B., Machado R.D., Pauciulo M.W., Thomson J.R., Phillips J.A., Loyd J.E., Nichols W.C., Trembath R.C. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat. Genet. 2000, 26:81-84.
27. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Choi J.Y., Ryoo H.M., Bae S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell Biol. 2000, 20:8783-8792.
28. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., Manning S.P., Swain P.M., Zhao S.C., Eustace B., Lappe M.M., Spitzer L., Zweier S., Braunschweiger K., Benchekroun Y., Hu X., Adair R., Chee L., FitzGerald M.G., Tulig C., Caruso A., Tzellas N., Bawa A., Franklin B., McGuire S., Nogues X., Gong G., Allen K.M., Anisowicz A., Morales A.J., Lomedico P.T., Recker S.M., Van Eerdewegh P., Recker R.R., Johnson M.L. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 2002, 70:11-19.
29. Lopez-Rovira T., Chalaux E., Massague J., Rosa J.L., Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 2002, 277:3176-3185.
30. Mbalaviele G., Sheikh S., Stains J.P., Salazar V.S., Cheng S.L., Chen D., Civitelli R. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell Biochem. 2005, 94:403-418.
31. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006, 4:e115.
32. Milat F., Ng K.W. Is Wnt signaling the final common pathway leading to bone formation?. Mol. Cell Endocrinol. 2009, 310:52-62.
33. 2+ pathways. Oncogene 1999, 18:7860-7872.
34. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16:251-263.
35. Moon R.T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296:1644-1646.
36. Morrell N.W., Yang X., Upton P.D., Jourdan K.B., Morgan N., Sheares K.K., Trembath R.C. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 2001, 104:790-795.
37. Nelson K.E., D'Angelo R., Foss M.L., Meister G.C., Hood D.D., Eisenach J.C. Intrathecal neostigmine and sufentanil for early labor analgesia. Anesthesiology 1999, 91:1293-1298.
38. Nickel J., Kotzsch A., Sebald W., Mueller T.D. A single residue of GDF-5 defines binding specificity to BMP receptor IB. J. Mol. Biol. 2005, 349:933-947.
39. Nojima, J., Kanomata, K., Takada, Y., Fukuda, T., Kokabu, S., Ohte, S., Takada, T., Tsukui, T., Yamamoto, T.S., Sasanuma, H., Yoneyama, K., Ueno, N., Okazaki, Y., Kamijo, R., Yoda, T., and Katagiri, T. 2010. Dual roles of Smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J. Biol. Chem. 285, 15577-15586.
40. Ono Y., Boldrin L., Knopp P., Morgan J.E., Zammit P.S. Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev. Biol. 2010, 337:29-41.
41. Phimphilai M., Zhao Z., Boules H., Roca H., Franceschi R.T. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone Miner. Res. 2006, 21:637-646.
42. Rawadi G., Vayssiere B., Dunn F., Baron R., Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 2003, 18:1842-1853.
43. Shore E.M., Xu M., Feldman G.J., Fenstermacher D.A., Cho T.J., Choi I.H., Connor J.M., Delai P., Glaser D.L., LeMerrer M., Morhart R., Rogers J.G., Smith R., Triffitt J.T., Urtizberea J.A., Zasloff M., Brown M.A., Kaplan F.S. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 2006, 38:525-527.
44. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol. 2003, 162:899-908.
45. Westendorf J.J., Kahler R.A., Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
46. Yan Y., Tang D., Chen M., Huang J., Xie R., Jonason J.H., Tan X., Hou W., Reynolds D., Hsu W., Harris S.E., Puzas J.E., Awad H., O'Keefe R.J., Boyce B.F., Chen D. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J. Cell Sci. 2009, 122:3566-3578.